IMR Press / FBL / Special Issues / neurological_neuropsychiatric_disorders

Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders

Submission deadline: 31 December 2024
Special Issue Editors
Special Issue Information

Dear Colleagues,

Neurological and neuropsychiatric disorders are being studied at multiple levels. What we experience as mental illness can be studied at the psychological level, with a specific a focus on psychological symptoms, cognitive dysfunctions and affective disorders, as well as on a biological level, to elucidate molecular, cellular and brain circuit mechanisms underlying these pathological states.

Many branches of Neuroscience can help us understand the underlying biological factors and neural computations behind brain alterations and psychiatric disorders, as well as determine where and how to focus research and treatment. Currently, the great majority of neurological and neuropsychiatric diseases lack effective disease-modifying treatments, thus highlighting the urgent need for new and effective therapeutic strategies. In recent years, non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS) and transcranial electric current stimulation (TES), have been developed. These techniques are currently being investigated in patients experiencing both neurological and neuropsychiatric disorders for diagnostic and therapeutic purposes.

This Special Issue highlights the most recent advances in experimental, clinical, and translational research in the fields of neurology and neuropsychiatry, focusing on neural correlates in the development of cognitive impairment and emotional disturbance. We invite authors to contribute original research articles focusing on (but not limited to) the following:

•    Etiology, pathogenesis and progression mechanisms;
•    Early diagnosis including biomarkers, bio-imaging, and biosensors;
•    Prophylactic, disease-modifying and therapeutic strategies;
•    Novel drug discovery and development, naturally driven biomedicines, natural bioactive molecules and vaccines;
•    Preclinical in vitro and animal models;
•    Bench-to-bedside translational research;
•    Bedside-to-bench translational research;
•    Non-invasive brain stimulation (NIBS) for diagnosis and treatment of neuropsychiatric disorders.

Comprehensive reviews, systematic reviews, and meta-analysis articles are also welcome.

Dr. Masaru Tanaka and Dr. Simone Battaglia

Guest Editors

Keywords
neurological diseases
psychiatric disorders
non-invasive brain stimulation
altered cognitive processes
neurocognitive disorders
neurodegenerative disorders
cognitive, behavioral, and functional disorders
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (5 Papers)
Back to top